Responses
Regular and young investigator award abstracts
Checkpoint blockade therapy
246 Clinicopathologic and genomic correlates of tumor mutational burden and its impact on PD-(L)1 inhibition efficacy in non-small cell lung cancer according to different PD-L1 expression subgroups
Compose a Response to This Article
Other responses
No responses have been published for this article.
